0 items USD 0.00Search
Your search for "globaldata nuclear power china market outlook 2025 2012 update capacity generation regulations" gave back 7221 results.
Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta - Pipeline Review, H2 2019 Summary According to the recently published report 'Inhibitor...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) - Pipeline Review, H1 2018 Summary Leucine Rich Repeat...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
This study focuses on China’s Cervical Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 1,800.00
China's demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 4,000.00
Retinoic Acid Receptor Alpha - Pipeline Review, H1 2020 Summary Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Retinoic Acid Receptor Alpha - Pipeline Review, H2 2019 Summary Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B...
Catalog:
Global Markets Direct
November 2019
Price: USD 3,500.00
China's demand for Diabetes Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 4,000.00
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) Drugs in Development by Therapy Areas and...
Catalog:
Global Markets Direct
August 2022
Price: USD 3,500.00
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H1 2019 Summary...
Catalog:
Global Markets Direct
April 2019
Price: USD 3,500.00
This study focuses on China’s Asthma Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 1,800.00
This study focuses on China’s Leukemia Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 1,800.00
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) Drugs in Development by Therapy Areas and...
Catalog:
Global Markets Direct
April 2022
Price: USD 3,500.00
China's demand for Lung Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 4,000.00
